Advertisement

Loading...

Praveg Ltd.

PRAVEG.BOBSE
Healthcare
Medical - Pharmaceuticals
194.40
-4.65(-2.34%)
Indian Market opens in 8h 7m

Praveg Ltd. Fundamental Analysis

Praveg Ltd. (PRAVEG.BO) shows weak financial fundamentals with a PE ratio of -193.52, profit margin of -1.10%, and ROE of -0.54%. The company generates $2.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.55
Current Ratio1.58

Areas of Concern

ROE-0.54%
Operating Margin4.19%
Cash Position2.86%
We analyze PRAVEG.BO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 30.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
30.2/100

We analyze PRAVEG.BO's fundamental strength across five key dimensions:

Efficiency Score

Weak

PRAVEG.BO struggles to generate sufficient returns from assets.

ROA > 10%
-0.39%

Valuation Score

Excellent

PRAVEG.BO trades at attractive valuation levels.

PE < 25
-193.52
PEG Ratio < 2
0.55

Growth Score

Weak

PRAVEG.BO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

PRAVEG.BO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.24
Current Ratio > 1
1.58

Profitability Score

Weak

PRAVEG.BO struggles to sustain strong margins.

ROE > 15%
-53.80%
Net Margin ≥ 15%
-1.10%
Positive Free Cash Flow
No

Key Financial Metrics

Is PRAVEG.BO Expensive or Cheap?

P/E Ratio

PRAVEG.BO trades at -193.52 times earnings. This suggests potential undervaluation.

-193.52

PEG Ratio

When adjusting for growth, PRAVEG.BO's PEG of 0.55 indicates potential undervaluation.

0.55

Price to Book

The market values Praveg Ltd. at 1.08 times its book value. This may indicate undervaluation.

1.08

EV/EBITDA

Enterprise value stands at 7.10 times EBITDA. This is generally considered low.

7.10

How Well Does PRAVEG.BO Make Money?

Net Profit Margin

For every $100 in sales, Praveg Ltd. keeps $-1.10 as profit after all expenses.

-1.10%

Operating Margin

Core operations generate 4.19 in profit for every $100 in revenue, before interest and taxes.

4.19%

ROE

Management delivers $-0.54 in profit for every $100 of shareholder equity.

-0.54%

ROA

Praveg Ltd. generates $-0.39 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.39%

Following the Money - Real Cash Generation

Operating Cash Flow

Praveg Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Praveg Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

PRAVEG.BO converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-193.52

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.55

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.08

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.24

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.58

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.01

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.02

vs 25 benchmark

How PRAVEG.BO Stacks Against Its Sector Peers

MetricPRAVEG.BO ValueSector AveragePerformance
P/E Ratio-193.5227.91 Better (Cheaper)
ROE-0.54%687.00% Weak
Net Margin-1.10%-45285.00% (disorted) Weak
Debt/Equity0.240.33 Strong (Low Leverage)
Current Ratio1.582795.76 Neutral
ROA-0.39%-13557.00% (disorted) Weak

PRAVEG.BO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Praveg Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ